Deborah Joan Morris, Director Systems, Support & ACVM of the Ministry for Primary Industries ("MPI"), acting
under delegated authority from the Director-General
of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 ("the Act"), that the following application has been made to register a trade name product under section 9(1)
of the Act:
Trade Name: Bravecto
Reference: A11019
Active Ingredient and Concentration: Fluralaner 112.5mg
Formulation Type: Tablet
General Use Claims:
For the control of tick and flea infestations on dogs for 12 weeks.
For use as part of a treatment strategy for flea allergy dermatitis (FAD).
Any person may make a written submission to the
director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
(a) must state in full the reasons for making the submission; and
(b) may state any decision sought on that application; and
(c) must be received by the director-general no later than 30 working days after the date of notification
in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant's information.
The following address is:
(a) where submissions on this application are to be sent; and
(b) where requests for copies of the public information relating to the application can be sent; and
(c) where public information relating to the application can be viewed; and
(d) the director-general's address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant's address for service is:
Schering-Plough Animal Health Limited, 33 Whakatiki Street, Trentham, Upper Hutt 5018. Postal Address: Private Bag 908, Upper Hutt 5140.
Dated at Wellington this 5th day of December 2013.
DEBORAH JOAN MORRIS, Director Systems, Support
& ACVM, Ministry for Primary Industries (acting under delegated authority).